-
Signature
-
/s/ Chad A. Keetch, as power of attorney
-
Issuer symbol
-
ENSG
-
Transactions as of
-
05 Feb 2026
-
Net transactions value
-
-$2,240,852
-
Form type
-
4
-
Filing time
-
09 Feb 2026, 17:53:54 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Snapper Suzanne D. |
CFO, Director |
29222 RANCHO VIEJO ROAD, SUITE 127, SAN JUAN CAPISTRANO |
/s/ Chad A. Keetch, as power of attorney |
09 Feb 2026 |
0001470396 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ENSG |
Common Stock |
Options Exercise |
$65,238 |
+4,129 |
+1.5% |
$15.80 |
273,333 |
05 Feb 2026 |
Direct |
F1 |
| transaction |
ENSG |
Common Stock |
Options Exercise |
$65,238 |
+4,129 |
+1.5% |
$15.80 |
277,462 |
06 Feb 2026 |
Direct |
F1 |
| transaction |
ENSG |
Common Stock |
Options Exercise |
$65,775 |
+4,129 |
+1.5% |
$15.93 |
281,591 |
05 Feb 2026 |
Direct |
F1 |
| transaction |
ENSG |
Common Stock |
Options Exercise |
$65,775 |
+4,129 |
+1.5% |
$15.93 |
285,720 |
06 Feb 2026 |
Direct |
F1 |
| transaction |
ENSG |
Common Stock |
Sale |
$134,839 |
-728 |
-0.25% |
$185.22 |
284,992 |
05 Feb 2026 |
Direct |
F1, F2 |
| transaction |
ENSG |
Common Stock |
Sale |
$37,457 |
-200 |
-0.07% |
$187.28 |
284,792 |
05 Feb 2026 |
Direct |
F1, F3 |
| transaction |
ENSG |
Common Stock |
Sale |
$105,651 |
-550 |
-0.19% |
$192.09 |
284,242 |
05 Feb 2026 |
Direct |
F1, F4 |
| transaction |
ENSG |
Common Stock |
Sale |
$124,628 |
-644 |
-0.23% |
$193.52 |
283,598 |
05 Feb 2026 |
Direct |
F1, F5 |
| transaction |
ENSG |
Common Stock |
Sale |
$339,625 |
-1,742 |
-0.61% |
$194.96 |
281,856 |
05 Feb 2026 |
Direct |
F1, F6 |
| transaction |
ENSG |
Common Stock |
Sale |
$406,130 |
-2,072 |
-0.74% |
$196.01 |
279,784 |
05 Feb 2026 |
Direct |
F1, F7 |
| transaction |
ENSG |
Common Stock |
Sale |
$314,012 |
-1,595 |
-0.57% |
$196.87 |
278,189 |
05 Feb 2026 |
Direct |
F1, F8 |
| transaction |
ENSG |
Common Stock |
Sale |
$143,712 |
-727 |
-0.26% |
$197.68 |
277,462 |
05 Feb 2026 |
Direct |
F1, F9 |
| transaction |
ENSG |
Common Stock |
Sale |
$432,334 |
-2,205 |
-0.79% |
$196.07 |
275,257 |
06 Feb 2026 |
Direct |
F1 |
| transaction |
ENSG |
Common Stock |
Sale |
$444,768 |
-2,268 |
-0.82% |
$196.11 |
272,989 |
06 Feb 2026 |
Direct |
F1 |
| transaction |
ENSG |
Common Stock |
Sale |
$19,720 |
-100 |
-0.04% |
$197.20 |
272,889 |
06 Feb 2026 |
Direct |
F1 |
| holding |
ENSG |
Common Stock |
|
|
|
|
|
56,340 |
05 Feb 2026 |
by Trust |
F10 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ENSG |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-4,129 |
-50% |
$0.000000 |
4,129 |
05 Feb 2026 |
Common Stock |
4,129 |
$15.80 |
Direct |
F1, F11 |
| transaction |
ENSG |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-4,129 |
-100% |
$0.000000 |
0 |
06 Feb 2026 |
Common Stock |
4,129 |
$15.80 |
Direct |
F1, F11 |
| transaction |
ENSG |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-4,129 |
-50% |
$0.000000 |
4,129 |
05 Feb 2026 |
Common Stock |
4,129 |
$15.93 |
Direct |
F1, F12 |
| transaction |
ENSG |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-4,129 |
-100% |
$0.000000 |
0 |
06 Feb 2026 |
Common Stock |
4,129 |
$15.93 |
Direct |
F1, F12 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: